unitedtherapeuticsclinicaltrials

沒有這個頁面的資訊。

由 LA Spikes 著作 · 2022 · 被引用 10 次 — Inhaled treprostinil is an approved therapy for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with ...

How United Therapeutics incorporates metabolomics into multi-omics workflow across pre-clinical, first-in-human, and late-stage clinical trials. How the broad- ...

沒有這個頁面的資訊。

Clinical Trials. United therapeutics 301. Status. Accepting Candidates. Age. 18 ... If on PAH-specific background oral therapy, subject is on stable therapy with ...

GlobalData's premium database of United Therapeutics Corp Clinical Trials helps in determining United Therapeutics Corp's go-to-market proposition and ...

United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.

Access United Therapeutics' Scientific Library to explore clinical data across various indications. Limited to sponsored studies and approved uses.

2023年4月18日 — Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS. Baseline patient data from the ...

Pre-clinical · Phase 1 · Phase 3 · Devices. Oral. ADVANCE Study Ralinepag (IP receptor agonist). Inhaled. TETON Studies (inhaled treprostinil). Infused.